Business Description
IMAC Holdings Inc
NAICS : 622310
SIC : 8093
ISIN : US44967K3023
Total Employee Number:
15Description
IMAC Holdings Inc is engaged in providing services related to proteomic products that identify and support oncology clinical treatment decisions and biopharmaceutical drug development. The Company has determined that it currently operates in a single segment, precision medicine in cancer treatment, located in a single geographic location, the United States.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -41.86 | |||||
Debt-to-Equity | -0.3 | |||||
Debt-to-EBITDA | -0.46 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -468.35 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -86.6 | |||||
3-Year EBITDA Growth Rate | 32.1 | |||||
3-Year EPS without NRI Growth Rate | 24.4 | |||||
3-Year FCF Growth Rate | 43.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 63.87 | |||||
9-Day RSI | 57.54 | |||||
14-Day RSI | 53.74 | |||||
3-1 Month Momentum % | -38.67 | |||||
6-1 Month Momentum % | -72.94 | |||||
12-1 Month Momentum % | 1.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.02 | |||||
Quick Ratio | 0.02 | |||||
Days Sales Outstanding | 454.93 | |||||
Days Payable | 3018.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -32.4 | |||||
Shareholder Yield % | -515.67 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -1817.39 | |||||
Operating Margin % | -34047.83 | |||||
Net Margin % | -54130.44 | |||||
EBITDA Margin % | -36386.96 | |||||
FCF Margin % | -21300 | |||||
OCF Margin % | -21300 | |||||
ROA % | -1114.79 | |||||
ROIC % | -136.47 | |||||
3-Year ROIIC % | -27.64 | |||||
ROC (Joel Greenblatt) % | -948.17 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 6.79 | |||||
EV-to-EBIT | -0.46 | |||||
EV-to-EBITDA | -0.47 | |||||
EV-to-Forward-EBITDA | 15.66 | |||||
EV-to-Revenue | 172.3 | |||||
EV-to-Forward-Revenue | 1.91 | |||||
EV-to-FCF | -0.81 | |||||
Earnings Yield (Greenblatt) % | -217.39 | |||||
FCF Yield % | -2721.67 |
GF Valueâ„¢
IMAC Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IMAC Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.0333333:1 Stock Split | 2023-09-08 | 3.12 (+7.66%) |
Show
Entries
Guru Commentaries on OTCPK:BACK
No articles.
Press Release
Articles on IMAC Holdings Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers